Lymphangioleiomyomatosis — Trials

Lymphangioleiomyomatosis — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01799538	Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis	recruiting	Phase 1 / Phase 2	100	National Heart, Lung, and Blood Institute (NHLBI)NIH	1	Aug 31, 2026	clinicaltrials
NCT06889168	Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)(LAMP-2)	recruiting	Phase 1	20	Columbia UniversityOTHER	1	Jan 21, 2026